J Med Microbiol International Journal of Systematic and Evolutionary Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Med Microbiol 46 (1997), 721-746; DOI: 10.1099/00222615-46-9-721
© 1997 Society for General Microbiology
ISSN 0022-2615
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TOWNER, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TOWNER, K. J.
Agricola
Right arrow Articles by TOWNER, K. J.

Clinical importance and antibiotic resistance of Acinetobacter spp.: Proceedings of a symposium held on 4-5 November 1996 at Eilat, Israel

K. J. TOWNER

Department of Microbiology and PHLS Laboratory, University Hospital, Queen's Medical Centre, Nottingham NG7 2UH

Corresponding author: Dr K. J. Towner.

Received January 16, 1997
Accepted February 11, 1997

Members of the genus Acinetobacter, particularly multiresistant strains of A. baumannii, are implicated in a wide spectrum of nosocomial infections, including bacteraemia, secondary meningitis and urinary tract infection, but have now assumed a particularly important role as agents of nosocomial pneumonia in intensive care units (ICUs). Rapid genotyping methods for the identification and typing of these organisms have allowed a better appreciation of the epidemiology and survival of these organisms in the hospital environment. Their emergence as significant pathogens seems to be related partly to their survival ability and partly to their ability to develop resistance rapidly to the major groups of antibiotics, resulting in a considerable selective advantage in environments (such as ICUs) with widespread and heavy use of antibiotics. Molecular and biochemical mechanisms of resistance to the major β-lactam, aminoglycoside and quinolone groups of antibiotics have now been elucidated in some detail for these organisms, and experimental models, including a mouse model of A. baumannii pneumonia, have been developed to examine the efficacy of different therapeutic regimens for difficult-to-treat-infections caused by these bacteria. ‘Non-classic’ antibiotic combinations—such as ticarcillin with clavulanic acid and sulbactam—seem to show promise for treating systemic infections caused by otherwise multiresistant strains, but revised screening procedures in the pharmaceutical industry may be required in the near future to select novel compounds with activity against multiresistant Acinetobacter spp. and other emerging gram-negative, non-fermentative bacilli in general.




This article has been cited by other articles:


Home page
 Am. J. Respir. Crit. Care Med.Home page
S. Knapp, C. W. Wieland, S. Florquin, R. Pantophlet, L. Dijkshoorn, N. Tshimbalanga, S. Akira, and T. van der Poll
Differential Roles of CD14 and Toll-like Receptors 4and 2 in Murine Acinetobacter Pneumonia
Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 122 - 129.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
A. Montero, J. Ariza, X. Corbella, A. Domenech, C. Cabellos, J. Ayats, F. Tubau, C. Borraz, and F. Gudiol
Antibiotic combinations for serious infections caused by carbapenem-resistant Acinetobacter baumannii in a mouse pneumonia model
J. Antimicrob. Chemother., December 1, 2004; 54(6): 1085 - 1091.
[Abstract] [Full Text] [PDF]

Home page
 The Annals of PharmacotherapyHome page
R. Jain and L. H Danziger
Multidrug-Resistant Acinetobacter Infections: An Emerging Challenge to Clinicians
Ann. Pharmacother., September 1, 2004; 38(9): 1449 - 1459.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
M. G. Smith, S. G. Des Etages, and M. Snyder
Microbial Synergy via an Ethanol-Triggered Pathway
Mol. Cell. Biol., May 1, 2004; 24(9): 3874 - 3884.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. P. Spence and K. J. Towner
Frequencies and mechanisms of resistance to moxifloxacin in nosocomial isolates of Acinetobacter baumannii
J. Antimicrob. Chemother., October 1, 2003; 52(4): 687 - 690.
[Abstract] [Full Text] [PDF]

Home page
 Appl. Environ. Microbiol.Home page
A. Petersen, J. S. Andersen, T. Kaewmak, T. Somsiri, and A. Dalsgaard
Impact of Integrated Fish Farming on Antimicrobial Resistance in a Pond Environment
Appl. Envir. Microbiol., December 1, 2002; 68(12): 6036 - 6042.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
A. Montero, J. Ariza, X. Corbella, A. Domenech, C. Cabellos, J. Ayats, F. Tubau, C. Ardanuy, and F. Gudiol
Efficacy of Colistin versus {beta}-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant Acinetobacter baumannii
Antimicrob. Agents Chemother., June 1, 2002; 46(6): 1946 - 1952.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
J. Klovins, G. P. Overbeek, S. H. E. van den Worm, H.-W. Ackermann, and J. van Duin
Nucleotide sequence of a ssRNA phage from Acinetobacter: kinship to coliphages
J. Gen. Virol., June 1, 2002; 83(6): 1523 - 1533.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
R. Pantophlet, J. A. Severin, A. Nemec, L. Brade, L. Dijkshoorn, and H. Brade
Identification of Acinetobacter Isolates from Species Belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii Complex with Monoclonal Antibodies Specific for O Antigens of Their Lipopolysaccharides
Clin. Vaccine Immunol., January 1, 2002; 9(1): 60 - 65.
[Abstract] [Full Text] [PDF]

Home page
 J. Bacteriol.Home page
D. M. Young and L. N. Ornston
Functions of the Mismatch Repair Gene mutS from Acinetobacter sp. Strain ADP1
J. Bacteriol., December 1, 2001; 183(23): 6822 - 6831.
[Abstract] [Full Text] [PDF]

Home page
 CVIHome page
R. Pantophlet, L. Brade, and H. Brade
Generation and Serological Characterization of Murine Monoclonal Antibodies against O Antigens from Acinetobacter Reference Strains
Clin. Vaccine Immunol., July 1, 2001; 8(4): 825 - 827.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
R. Pantophlet, A. Nemec, L. Brade, H. Brade, and L. Dijkshoorn
O-Antigen Diversity among Acinetobacter baumannii Strains from the Czech Republic and Northwestern Europe, as Determined by Lipopolysaccharide-Specific Monoclonal Antibodies
J. Clin. Microbiol., July 1, 2001; 39(7): 2576 - 2580.
[Abstract] [Full Text] [PDF]

Home page
 Innate ImmunityHome page
E. V. Vinogradov, R. Pantophlet, H. Brade, and O. Holst
Structural and serological characterisation of the O-antigenic polysaccharide of the lipopolysaccharide from Acinetobacter strain 96 (DNA group 11)
Innate Immunity, April 1, 2001; 7(2): 113 - 118.
[Abstract] [PDF]

Home page
 J Med MicrobiolHome page
L. GUARDABASSI, L. DIJKSHOORN, J.-M. COLLARD, J.E. OLSEN, and A. DALSGAARD
Distribution and in-vitro transfer of tetracycline resistance determinants in clinical and aquatic Acinetobacter strains
J. Med. Microbiol., October 1, 2000; 49(10): 929 - 936.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
O. Mimoz, S. Leotard, A. Jacolot, C. Padoin, K. Louchahi, O. Petitjean, and P. Nordmann
Efficacies of Imipenem, Meropenem, Cefepime, and Ceftazidime in Rats with Experimental Pneumonia Due to a Carbapenem-Hydrolyzing beta -Lactamase-Producing Strain of Enterobacter cloacae
Antimicrob. Agents Chemother., April 1, 2000; 44(4): 885 - 890.
[Abstract] [Full Text]

Home page
 Infect. Immun.Home page
H. Tiwana, C. Wilson, J. Pirt, W. Cartmell, and A. Ebringer
Autoantibodies to Brain Components and Antibodies to Acinetobacter calcoaceticus Are Present in Bovine Spongiform Encephalopathy
Infect. Immun., December 1, 1999; 67(12): 6591 - 6595.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
R. Pantophlet, L. Brade, and H. Brade
Use of a Murine O-Antigen-Specific Monoclonal Antibody To Identify Acinetobacter Strains of Unnamed Genomic Species 13 Sensu Tjernberg and Ursing
J. Clin. Microbiol., June 1, 1999; 37(6): 1693 - 1698.
[Abstract] [Full Text]

Home page
 CVIHome page
R. Pantophlet, L. Brade, and H. Brade
Identification of Acinetobacter baumannii Strains with Monoclonal Antibodies against the O Antigens of Their Lipopolysaccharides
Clin. Vaccine Immunol., May 1, 1999; 6(3): 323 - 329.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. N. Husni, L. S. Goldstein, A. C. Arroliga, G. S. Hall, C. Fatica, J. K. Stoller, and S. M. Gordon
Risk Factors for an Outbreak of Multi-Drug-Resistant Acinetobacter Nosocomial Pneumonia Among Intubated Patients
Chest, May 1, 1999; 115(5): 1378 - 1382.
[Abstract] [Full Text] [PDF]

Home page
 DTBHome page
Tackling antimicrobial resistance
DTB, February 1, 1999; 37(2): 9 - 16.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
M. J Struelens
The epidemiology of antimicrobial resistance in hospital acquired infections: problems and possible solutions
BMJ, September 5, 1998; 317(7159): 652 - 654.
[Full Text]

Home page
 Appl. Environ. Microbiol.Home page
L. Guardabassi, A. Petersen, J. E. Olsen, and A. Dalsgaard
Antibiotic Resistance in Acinetobacter spp. Isolated from Sewers Receiving Waste Effluent from a Hospital and a Pharmaceutical Plant
Appl. Envir. Microbiol., September 1, 1998; 64(9): 3499 - 3502.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 1997 Society for General Microbiology.